Sartorius Stedim Biotech Shows Solid Liquidity

Sartorius Stedim Biotech (FR:DIM) has released an update.

Sartorius Stedim Biotech reported a strong liquidity position in its half-year statement, with a total of 46,292 shares and €2,521,189.91 in cash on their liquidity account as of June 30th, 2024. The company, a key international player in the biopharmaceutical industry, supports the production of biotech medications and has a global presence with a workforce of over 10,600 employees.

For further insights into FR:DIM stock, check out TipRanks’ Stock Analysis page.